Practical Management of Thyroid Cancer (2^nd Ed., 2nd ed. 2018)
A Multidisciplinary Approach

The new edition of this book highlights the recent advances and state-of-the art in surgical and non-surgical management of thyroid cancer. Readers will learn about the latest advances and recommendations in the field, from molecular studies and biomarkers to the changing epidemiology, kinase inhibition in drug discovery and new surgical approaches, such as intra-operative neural monitoring and robotics. The management of differentiated thyroid cancer as well as childhood cancer, survivorship and clinical trial design and findings and how these fit into cancer management are discussed in detail.

This comprehensive volume provides an overview of the current world literature and outlines the practical aspects of management from world leaders in this field and helps clinicians and patients on practical matters. With a selection of authors from around the world it draws on international experience giving a global perspective to the topic. Following on from the success of the firstedition, it uses a multidisciplinary, evidence-based approach centered on the patient, discussing guidelines and how these have improved the quality of care and outcomes. 

 This guide is aimed mainly at thyroidologists of all disciplines, (in training or experts) students, non-specialist clinicians, nursing staff, all the disciplines involved in a multidisciplinary team such as surgeons ? Head & Neck or Endocrine and General Surgeons,  Oncologists, Endocrinologists, Nuclear Medicine Physicians, Nuclear Medicine Physicists, Radiologists, Pathologists, Specialist  Nurses, Geneticists, Clinical Psychologists, Palliative Care Physicians and, of course, patients. 

1. Pragmatism, Precision Oncology, International Partnership for Research and Quality-The New Paradigm for Thyroid Cancer.- Section I. Multidisciplinary Approach to Management of Thyroid Cancer.- 2. The UK Evidence-Based Guidelines   for the Management of Thyroid Cancer: Key Recommendations.-  3. The 2015 American Thyroid Association Evidence-Based Guidelines for Management of Patients with Thyroid Nodules and Differentiated Thyroid Cancer:  Key Recommendations.-  4. Thyroid Cancer: One Doctor-Patient Partnership -The Newcastle Butterfly Model.- Section II. The Diagnosis of Thyroid Cancer.- 5. Molecular Diagnosis of Thyroid Nodules.- 6. Ultrasonography in Diagnosis and Management of Thyroid Cancer –Current International Recommendations .- Section III. Initial Thyroid Surgery.- 7. The 21st Century Endocrine Surgeon.- 8. Management of Cervical Lymph Nodes in Differentiated Thyroid Cancer.- 9. Advances in Thyroid Surgery.- Section IV. Non surgical Management ofDifferentiated Thyroid Cancer.- 10. Risk Stratification and Current Management of Low Risk Thyroid Cancer.- 11. Management of Low risk Papillary Thyroid Carcinomo and Papillary  Cancer  and Microcarcinoma-the Japanese experience.- 12.   Radioiodine Ablation – Current Status.- 13. Dosimetric Approaches  – Current Concepts.- 14. External Radiation in Differentiated Thyroid Cancer in the era of IMRT and modern radiation planning techniques.- Section V. Follow up and Longterm Management of Differentiated Thyroid Cancer.- 15. Thyroglobulin.- 16. Management of Post-Operative Hypocalcemia .- 17. Radioiodine Refractory Thyroid Cancer .- Section VI. Medullary Thyroid Carcinoma.- 18. Medullary Thyroid Cancer :Surgical Management.- 19. Medullary Thyroid Cancer: Diagnosis and Non Surgical Management.- 20.  Familial Non-Medullary Thyroid Cancer.- Section VII. Thyroid Cancer in Children.- 21. Pediatric Differentiated Thyroid Carcinoma.- Section VIII. Aggressive ThyroidCancers.- 22. Anaplastic Thyroid Cancer.- 23. Palliative care.- Section IX. Future Developments and Directions for Research in  Thyroid Cancer.- 24.   Translational Research and Genomics Driven Trials in Thyroid Cancer.- 25. Thyroid  Cancer  Trials.- 26. The Barriers to Uniform Implementation of Clinical Practice Guidelines (CPG) for Thyroid Cancer.- 27. Survivorship: The Role of the Clinical Psychologist and the Clinical Nurse Specialist in Thyroid Cancer Care.

Dr Ujjal Mallick, MBBS  MS  FRCPE (Hon)  FRCP(Hon) FRCR  Consultant Clinical Oncologist Formerly Consultant  Oncologist and  past Chair, Multidisciplinary thyroid cancer team (MDT), Freeman Hospital, Newcastle upon Tyne, UK, a centre of excellence for thyroid cancer. Chief Investigator of the first  UK National Thyroid Cancer Trial -Hilo-( NEJM 2012) which helped modify  international  guidelines and practice  and of the on-going second UK trial-IoN. One of the lead authors of the first UK National guideline. The MDT obtained many prestigious national awards including–Best NHS  "Hospital Doctor" Oncology Team of the Year” Award 2007, Best Thyroid cancer MDT in NHS Peer Review 2011, first prize in NHS innovations award 2007 and others. He  initiated an acclaimed MD clinic  involving an expert thyroid cancer patient. Current interests are trials, biomarkers and guideline implementation. 

DrClive Harmer MB FRCR FRCP. Clinical Oncologist Consultant in Clinical Oncology at St. George’s Healthcare NHS Trust and The Royal Marsden NHS Trust (where he was head of the Thyroid unit) until August 2005. Recognized teacher of the University of London and Honorary Senior Lecturer at the Institute of Cancer Research.